ReviewFrontiers in oncology2026

Targeting cancer hallmarks with microbiome-derived bacteriocins and postbiotics: molecular mechanisms and translational opportunities in oncology.

Radhamanalan GuhanrajPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.